Bushido Capital US Equity ETF (SMRI)

Assets	$493.58M
Expense Ratio	0.71%
PE Ratio	15.86
Shares Out	14.29M
Dividend (ttm)	$0.41
Dividend Yield	1.14%
Ex-Dividend Date	Mar 30, 2026
Payout Frequency	Quarterly
Payout Ratio	18.08%

Volume	7,515
Open	36.18
Previous Close	35.38
Day's Range	35.45 - 37.02
52-Week Low	26.95
52-Week High	37.19
Beta	0.86
Holdings	52
Inception Date	Sep 14, 2023

About SMRI

Fund Home Page

The Bushido Capital US Equity ETF (SMRI) is an exchange-traded fund that mostly invests in total market equity. The fund actively manages an equally weighted portfolio of 30 to 50 US stocks believed to be undervalued but financially attractive. The funds stock selection involves a fundamental value approach. SMRI was launched on Sep 14, 2023 and is issued by Bushido.

• Asset Class: Equity
• Category: Mid-Cap Value
• Region: North America
• Stock Exchange: NASDAQ
• Ticker Symbol: SMRI
• ETF Provider: Bushido

Top 10 Holdings

20.96% of assets

Name	Symbol	Weight
SLB N.V.	SLB	2.14%
Permian Resources Corporation	PR	2.14%
Newmont Corporation	NEM	2.12%
Merck & Co., Inc.	MRK	2.11%
Expand Energy Corporation	EXE	2.09%
Neurocrine Biosciences, Inc.	NBIX	2.08%
Paychex, Inc.	PAYX	2.07%
Zoom Communications, Inc.	ZM	2.07%
Diamondback Energy, Inc.	FANG	2.07%
Royalty Pharma plc	RPRX	2.07%

Dividend History

Ex-Dividend	Amount	Pay Date
Mar 30, 2026	$0.06604	Mar 31, 2026
Dec 23, 2025	$0.13447	Dec 24, 2025
Sep 29, 2025	$0.14942	Sep 30, 2025
Jun 27, 2025	$0.05509	Jun 30, 2025
Mar 28, 2025	$0.1386	Mar 31, 2025
Dec 30, 2024	$0.30629	Dec 31, 2024

Performance

SMRI had a total return of 16.85% in the past year, including dividends. Since the fund's inception, the average annual return has been 15.93%.